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Background: Porphyromonas gingivalis lipopolysaccharide (LPS) is a crucial virulence factor strongly associated with
chronic periodontitis which is the primary cause of tooth loss in adults. It exhibits remarkable heterogeneity
containing tetra-(LPS1435/1449) and penta-(LPS1690) acylated lipid A structures. Human gingival fibroblasts (HGFs) as
the main resident cells of human gingiva play a key role in regulating matrix metalloproteinases (MMPs) and
contribute to periodontal homeostasis. This study investigated the expression and regulation of MMPs1-3 and tissue
inhibitors of MMP-1 (TIMP-1) in HGFs in response to P. gingivalis LPS1435/1449 and LPS1690 and hexa-acylated E. coli
LPS as a reference. The expression of MMPs 1–3 and TIMP-1 was evaluated by real-time PCR and ELISA.
Results: The MMP-3 mRNA and protein were highly upregulated in P. gingivalis LPS1690- and E. coli LPS-treated cells,
whereas no induction was observed in P. gingivalis LPS1435/1449-treated cells. On the contrary, the expression of
MMP-1 and −2 was not significantly affected by P. gingivalis LPS lipid A heterogeneity. The TIMP-1 mRNA was
upregulated in P. gingivalis LPS1435/1449- and E. coli LPS-treated cells. Next, signal transduction pathways involved in
P. gingivalis LPS-induced expression of MMP-3 were examined by blocking assays. Blockage of p38 MAPK and ERK
significantly inhibited P. gingivalis LPS1690-induced MMP-3 expression in HGFs.
Conclusion: The present findings suggest that the heterogeneous lipid A structures of P. gingivalis LPS differentially
modulate the expression of MMP-3 in HGFs, which may play a role in periodontal pathogenesis.
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Periodontal disease is a bacterially induced and highly
common chronic inflammatory condition in humans,
and severe periodontal disease (periodontitis) remains
the major cause of tooth loss in adult population
worldwide [1]. Dysregulated host response to patho-
genic plaque biofilm critically contributes to destruc-
tive inflammation resulting in tissue damage and
alveolar bone loss [2]. Porphyromonas gingivalis is a* Correspondence: ljjin@hkucc.hku.hk
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reproduction in any medium, provided the orkeystone periodontal pathogen in the mixed microbial
community and it releases copious amount of lipo-
polysaccharide (LPS) which perpetually interacts with
host cells, thereby significantly contributing to peri-
odontal pathogenesis [1-4].
LPS is a potent immuno-inflammatory modulator
which causes serious complications in host. It is
comprised of three major components viz. outermost
O-antigen, core oligosaccharide regions and inner-
most lipid A [3]. Lipid A is the biologically most ac-
tive component of LPS that imparts the endotoxin
activity. Its structure differs widely among Gram-negative
bacteria species depending on the differences in compositionLtd. This is an Open Access article distributed under the terms of the Creative
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iginal work is properly cited.
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sites and substituted groups attached to the phosphate
residues [3]. The canonical lipid A structure in
Escherichia coli LPS is a hexa-acylated diphosphorylated
glucosamine disaccharide. Previous studies have shown
that P. gingivalis possesses highly heterogeneous lipid A
structures containing penta-acylated LPS1690 and tetra-
acylated LPS1435/1449, and this structural discrepancy may
critically account for contrasting biological activities in-
duced by P. gingivalis LPS [3,4].
Human gingival fibroblasts (HGFs) are the major cell
type in human gingiva [5-7]. They play a key role in
maintenance and remodeling of extra cellular matrix
(ECM) by producing various structural components,
such as collagen, elastin, glycoprotein and glycosamino-
glycans. In addition, HGFs also synthesize and secrete
various members of matrix metalloproteinases (MMPs)
in response to P. gingivalis LPS challenge, which ultim-
ately contribute to periodontal tissue destruction [8].
MMPs are a family of structurally and functionally re-
lated proteolytic enzymes containing a zinc-binding
catalytic domain and they are active against the compo-
nents of ECM [8-10]. The activity of MMPs is largely
regulated by several naturally occurring inhibitors like
tissue inhibitors of metalloproteinases (TIMPs) [11].
Overall, there is a remarkable balance between MMPs
and TIMPs in periodontal connective tissues and dis-
turbance of this balance is therefore critically implicated
in the destruction of periodontal tissues [12,13]. In nor-
mal conditions, MMPs are involved in the remodeling
and turnover of periodontal tissues under the strict con-
trol of TIMPs, which bind specifically to the active site
of the enzyme thereby maintaining the equilibrium be-
tween degradation and regeneration of ECM [8,14]. In-
creased production of MMPs 1–3 is observed in chronic
inflammatory condition such as periodontitis that results
in excessive connective tissue breakdown [14,15]. MMPs
such as MMP-1, -2, -3, -9 and −13 are synthesized in
periodontal tissues in response to periodontopathic bac-
teria like P. gingivalis. Previous studies have suggested
that LPS could regulate the MMP expression in various
host cell types including HGFs [10,16].
Currently, there are no studies on the role of P. gingivalis
LPS lipid A heterogeneity with respect to expression of
MMPs in HGFs. The present study therefore aimed to in-
vestigate the expression and regulation of MMPs 1–3 and
TIMP-1 in HGFs in response to the different isoforms of
P. gingivalis LPS1435/1449 and P. gingivalis LPS1690 as well
as E. coli LPS as a reference. This study sheds light on
the regulation of MMP expression and underlying sig-
nal transduction pathways in HGFs in response to
heterogeneous P. gingivalis LPS, which could have
important implications in the pathogenesis of peri-
odontal disease.Results
Heterogeneous P. gingivalis LPS lipid A structures
differentially modulate MMPs 1–3 and TIMP-1 mRNAs
The dose-dependent experiments showed that both
P. gingivalis LPS1435/1449 and LPS1690 differentially
modulated the expression of MMP-3 transcript. The
latter (0.1-10 μg/ml) markedly upregulated the ex-
pression of MMP-3 mRNA while the former did not
affect the expression (Figure 1c). Similarly, E. coli
LPS (0.1-10 μg/ml) significantly upregulated MMP-3
expression. Both isoforms of P. gingivalis LPS upregulated
to different extent the expression of MMP-1 and MMP-2
mRNAs, while E. coli LPS significantly upregulated the ex-
pression of these transcripts (Figures 1a and b). TIMP-1
mRNA expression was significantly induced in P.
gingivalis LPS1435/1449- and E. coli LPS-treated cells, and
no significant induction was observed following P.
gingivalis LPS1690 stimulation (Figure 1d).
Notably, MMP-3 transcript was differentially expressed
in the cells treated by the two isoforms of P. gingivalis
LPS. P. gingivalis LPS1690 significantly upregulated MMP-
3 mRNA expression at 24 and 48 h, while E. coli LPS
showed prompt expression at 12 h (Figure 2c). MMP-2
mRNA was significantly upregulated by both P. gingivalis
LPS1435/1449 and LPS1690 at 48 h (Figure 2b), and MMP-1
transcript was significantly upregulated by P. gingivalis
LPS1690 (Figure 2a). E. coli LPS significantly upregulated
both MMP-1 and MMP-2 mRNA expression. TIMP-1
transcript was differently modulated by P. gingivalis
LPS1435/1449 and LPS1690. The former significantly upre-
gulated its expression at 24 and 48 h, so did E. coli LPS
at 48 h.
P. gingivalis LPS1690 significantly upregulates MMP-3
protein expression
Both dose- and time-dependent experiments showed
that MMP-3 protein was differentially modulated by
P. gingivalis LPS1435/1449 and LPS1690 in consistent with
its transcript expression profile (Figure 3). P. gingivalis
LPS1690 at 1 μg/ml and 10 μg/ml significantly
upregulated MMP-3 protein expression in a time-
dependent manner (12–48 h) (Figure 3c). The MMP-3
level detected in the culture supernatant was greatly
higher than that in the cellular fraction (Figures 3a and
b). Similar observations occurred in E. coli LPS-treated
cells. Moreover, the MMP-3 level induced by P. gingivalis
LPS1690 was significantly greater than that stimulated by
P. gingivalis LPS1435/1449 (Figures 3a-c).
Next, western blot analysis confirmed that MMP-3
protein markedly increased in P. gingivalis LPS1690- and
E. coli LPS-treated cells at 48 h, while P. gingivalis
LPS1435/1449 did not induce MMP-3 at a notable level
(Figures 4a and c).
Figure 1 Dose-dependent expression of MMPs 1−3 and TIMP-1 mRNAs in P. gingivalis LPS-treated HGFs. Expression of MMP-1 (a), MMP-2
(b) MMP-3 (c) and TIMP-1(d) mRNAs after the stimulation of P. gingivalis (Pg) LPS1435/1449, LPS1690 and E. coli LPS in a dose-dependent assay
(1 ng/ml, 10 ng/ml, 100 ng/ml, 1 μg/ml and 10 μg/ml) for 24 h. The expression of mRNAs was measured by real-time qPCR. Each bar represents
the mean ± SD of three independent experiments with three replicates. *Significant difference (p < 0.05) as compared with the controls without
LPS treatment.
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affected by P. gingivalis LPS and E. coli LPS
Basal expression of MMP-2 was observed at 24 h, and
increased at 48 h (Figures 4 and 5). With reference to
the control, P. gingivalis LPS and E. coli LPS did not
significantly affect the expression levels of MMP-2
proteins (Figures 4a and b). Gelatin zymograms re-
vealed that the MMP-2 presented in two forms includ-
ing pro-MMP-2 (72 kDa) and active-MMP-2 (68 kDa).
In both culture supernatant (Figure 5a and b) and cellular
fraction (Figure 5c and d), the activity of MMP-2 at 24
and 48 h was not significantly affected by P. gingivalis LPS
and E. coli LPS.
P. gingivalis LPS1690 induces MMP-3 expression via MAPK
signaling pathway
Blocking assays were performed to elucidate the involve-
ments of NF-ĸB and MAPK signaling pathways of P.
gingivalis LPS1690 induced MMP-3 expression in HGFs.
Both ERK inhibitor (U1026) and p38 MAPK inhibitor
(SB202190) significantly suppressed the expression levelsof MMP-3 transcript (Figure 6a) and protein (Figure 6b)
in P. gingivalis LPS1690- and E. coli LPS-treated cells.
Notably, U1026 inhibited MMP-3 expression to a greater
extent with reference to SB202190. The expression of
MMP-3 was not significantly reduced by IKK-2 inhibitor
IV in P. gingivalis LPS1690-treated cells, whereas it sig-
nificantly suppressed MMP-3 in E. coli LPS-treated cells
(Figure 6).
Discussion
Periodontal disease is a complex inflammatory disease
initiated by pathogenic plaque biofilms and results in de-
struction of tooth-supporting tissues and alveolar bone
[17,18]. Proteolytic enzymes like MMPs play a major
role in the degradation of collagens in periodontal tis-
sues. The expression and regulation of MMPs and
TIMPs in HGFs are therefore crucial for maintenance of
tissue homeostasis and periodontal health. Although
many studies have been performed to elucidate the
mechanisms involved in the synthesis and regulation of
MMPs in periodontal research, no studies are available
Figure 2 Time-dependent expression of MMPs 1−3 and TIMP-1 mRNAs in P. gingivalis LPS-treated HGFs. Expression of MMP-1 (a), MMP-2
(b) MMP-3 (c) and TIMP-1(d) mRNAs after the stimulation of P. gingivalis (Pg) LPS1435/1449 (1 μg/ml), LPS1690 (1 μg/ml) and E. coli LPS (1 μg/ml) in a
time-dependent assay (2–48 h). The expression of mRNAs was measured by real-time qPCR. Each bar represents the mean ± SD of three
independent experiments with three replicates. *Significant difference (p < 0.05) as compared with the controls without LPS treatment.
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on the expression of MMPs and the underlying regula-
tory mechanisms.
MMP-3 is known as stromelysin which has both
elastinolytic and collagenolytic activities that degrade
basement membrane components such as laminin, elas-
tin fibronectin as well as collagen types II, III, IV, V, IX,
X and XI [8,19]. Its level could significantly increase
following the stimuli of pro-inflammatory cytokines,
growth factors and LPS [14,20-22]. It has been shown
that HGFs could upregulate the expression of MMP-3
due to the effects of pro-inflammatory cytokines such as
IL-1β and TNF-α [23-25]. The current study showed
that the expression of MMP-3 mRNA and protein was
markedly upregulated by P. gingivalis LPS1690, whereas no
induction was observed in cells treated with P. gingivalis
LPS1435/1449, indicating that the heterogeneous lipid A
structures of P. gingivalis LPS may differentially modulate
the expression of MMP-3 in HGFs. Moreover, TIMP-1 ex-
pression was differently modulated by the two isoforms of
P. gingivalis LPS as well. It functions as an inhibitor ofMMPs by forming non-covalent complexes with MMPs.
It has recently been shown that MMP-3 and TIMP-1 vari-
ants may significantly contribute to chronic periodontitis
and disease progression [26]. The imbalance between
MMPs and TIMPs has been implicated in periodontal tis-
sue destruction [27].
P. gingivalis has long been recognized as a major
periodontopathogen [28]. Recently, it is regarded as a
keystone pathogen due to its ability to significantly influ-
ence the oral microbial community by modulating the
innate host response [29,30]. Moreover, this bacterium
adopts multiple pathogenic mechanisms to evade or
subvert the host immune system [31-33]. Notably, P.
gingivalis LPS exhibits significant structural heterogen-
eity with both isoforms of LPS1435/1449 and LPS1690, and
our recent studies show that they differentially affect the
innate host defense and underlying signaling pathways,
thereby contributing to the pathogenesis of periodontal
disease [4,34,35]. The current observation that the dif-
ferent isoforms of P. gingivalis LPS modulate the ex-
pression of MMP-3 and TIMP-1 may represent an
Figure 3 P. gingivalis LPS1690 significantly upregulates the
expression of MMP-3 proteins. Expression of MMP-3 proteins in
the culture supernatants (a) and cellular fractions (b) of HGFs after
the stimulation of P. gingivalis (Pg) LPS1435/1449, LPS1690 and E. coli
LPS in a dose-dependent assay (1 ng/ml, 10 ng/ml, 100 ng/ml,
1 μg/ml and 10 μg/ml) for 24 h. Time-dependent expression of
MMP-3 proteins in the culture supernatants (c) of HGFs after the
stimulation of P. gingivalis LPS1435/1449 (1 μg/ml), LPS1690 (1 μg/ml)
and E. coli LPS (1 μg/ml) for 2–48 h. The protein expression levels
were measured by ELISA. Each bar represents the mean ± SD of two
independent experiments with three replicates. Significant difference
as compared with the controls without LPS treatment, *p < 0.05.
Significant difference between the cells treated with P. gingivalis
LPS1435/1449 and LPS1690 respectively,
†p < 0.05. Significant difference
between the cells treated with P. gingivalis LPS and E. coli LPS
respectively, #p < 0.05.
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ious species to disturb the physiological tissue remod-
eling and tissue homeostasis, leading to the initiation
of periodontal disease.
P. gingivalis and its virulence attributes such as LPS
can stimulate various cells types to secrete MMPs in-
cluding MMP-3 [36,37]. On the contrary, some studies
have suggested that P. gingivalis LPS may not induce
MMPs such as MMP-1, -2 and −9 [38]. A study
performed on gingival epithelial cells using P. gingivalis
LPS and E. coli LPS showed that neither LPS nor IL-1β
induced MMP-2 or MMP-9 [39]. Studies on tissue
models such as synovial membranes dissected from rat
knee joints showed induction of MMP-1, -3 and −9
mRNA levels but not MMP-2 in response to LPS stimu-
lation [40]. However, foregoing studies have not consid-
ered the heterogeneous nature of bacterial LPS lipid A
structures. Therefore, the conflicting findings of the pre-
vious studies could to some extent be due to different
isoforms of P. gingivalis LPS as demonstrated in the
present study.
In the present study, E. coli LPS-treated HGFs
exhibited rapid and significant induction of MMPs 1
and 2 mRNAs with reference to the cells treated with P.
gingivalis LPS1690. One possibility for this observation
may be the higher responsiveness of HGFs to hexa-
acylated nature of the E. coli LPS as compared to the
penta-acylated structure of P. gingivalis LPS1690. This
notion is consistent with previous findings that E. coli
LPS is a potent inducer of the production of MMPs in
fibroblast-like synovial cells and rat chondrocytes, as
well as other innate host response molecules in HGFs
and gingival/oral epithelia [41,42]. Moreover, it was
noted that both P. gingivalis LPS1435/1449 and E. coli
LPS significantly upregulated the expression of MMP-2
mRNA but not its protein as compared to the controls.
A number of factors may account for this finding, such
as the stability of mRNA, its processing and splicing
patterns, half-life of the target protein and post-
translational modifications [43,44]. Therefore, in the
present study increase in MMP-2 mRNA expression
level may not be necessarily reflected at its protein
level.
TIMPs exhibit high affinity for binding with MMPs
and lead to inhibition of their activities. In the present
study, TIMP-1 mRNA was upregulated by P. gingivalis
LPS1435/1449-treated HGFs, while no significant up-
regulation was observed in P. gingivalis LPS1690-stimu-
lated cells. The current results may not be comparable
with previous studies in which the structural heterogen-
eity of LPS was not fully considered [45-49]. This omis-
sion may account for the conflicting reports in the
literature. Hence, some studies have observed lower
TIMP-1 levels in the conditioned media of HGFs in
Figure 4 MMP-2 and −3 as well as TIMP-1 protein expression in P. gingivalis LPS- and E. coli LPS-treated HGFs. Confluent HGFs were
stimulated with P. gingivalis (Pg) LPS1435/1449 (1 μg/ml), LPS1690 (1 μg/ml) and E. coli LPS (1 μg/ml) at 24 h and 48 h. Culture supernatants of
40 μg were subjected to SDS-PAGE and probed with anti-rabbit polyclonal MMP-2 (1:1000), MMP-3 (1:1000) and TIMP-1 (1:1000) antibodies. Blots
were re-probed with α-Tubulin to confirm equal loading in samples. MMP-2: 64 kDa; MMP-3: 54 kDa; TIMP-1: 28 kDa and Tubulin: 50 kDa (a).
Quantification of band intensities was performed by ImageJ software. The fold increase values of proteins MMP-2 (b), MMP-3 (c) and TIMP-1
(d) as compared with α-Tubulin are shown in the graphs. One representative blot was shown from three independent experiments. *Significant
difference (p < 0.05) as compared with the data at 24 h.
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studies have noted the increased expression level of
TIMP-1 in gingival crevicular fluid of periodontitis pa-
tients [45,47]. Moreover, periodontal treatment could
alter the balance between MMP-3 and TIMP-1 [46,48].
Based upon the current findings, further study may
be warranted to explore the association of different
isoforms of P. gingivalis LPS with periodontal conditions
in periodontal patients and the possible effect of peri-
odontal treatment on the expression of these LPS
isoforms by P. gingivalis. In addition, the discrepancy
observed in TIMP-1 mRNA and protein expression fol-
lowing the stimulation of both P. gingivalis LPS1435/1449
and E. coli LPS in HGFs could be due to the complex
regulation of transcription and translation [43,44].
LPS is the major immuno-stimulatory component of
P. gingivalis which has shown to be capable of
interacting with TLRs. Binding of LPS to TLRs activates
the downstream signal transduction pathways such as
NF-ĸB and MAPK [50,51]. Previous studies havesuggested that the activation of MMPs could be through
both NF-ĸB and MAPK signaling [23,52-54]. The
present study demonstrated that p38 MAPK and ERK
are critically involved in P. gingivalis LPS1690- and E. coli
LPS-induced expression of MMP-3 in HGFs. This find-
ing is supported by a previous study that p38 MAPK
and ERK1/2 pathways are essential for the expression
and regulation of MMPs in various cell types in response
to LPS [54]. ERK, JNK and p38 MAPK pathways play
vital roles in regulating the expression of MMPs induced
by various stimulants such as cytokines [53,55,56]. It is
noteworthy that the nature of the stimuli could result in
specific signal transduction pathway in the same cell
type. For instance, MAPK inhibitor significantly reduced
the MMP-3 production in HGFs stimulated with IL-1β,
but not with epidermal growth factor [23]. In addition,
NF-ĸB pathway may be involved in regulation of MMP-3
expression in rabbit dermal fibroblasts, human saphe-
nous vein and rabbit aortic smooth muscle cells [57,58].
The present study showed that NF-ĸB signaling is not
Figure 5 Detection of MMP-2 in supernatant (a) and cellular fraction (c) of HGFs by gelatin zymography and molecular weight
positions of pro-MMP-2 (72 kDa) and active-MMP-2 (68 kDa). 5a: Lane1: molecular weight marker; Lane 2: untreated conditioned medium at
48 h; Lane 3: untreated conditioned medium at 24 h; Lanes 4–5: P. gingivalis (Pg) LPS1435/1449 -treated culture medium at 24 h and 48 h; Lanes
6–7: P. gingivalis LPS1690 -treated medium at 24 h and 48 h; Lanes 8–9: E. coli LPS-treated culture medium at 24 h and 48 h, respectively. 5c:
Lane1: Marker; Lanes 2–3: untreated cellular component at 48 h and 24 h; Lanes 4–5: P. gingivalis (Pg) LPS1435/1449 -treated cellular component at
48 h and 24 h; Lanes 6–7: P.gingivalis LPS1690- treated cellular component at 48 h and 24 h; Lanes 8–9: E-coli LPS-treated cellular component at
48 h and 24 h, respectively. Quantification of band intensities was performed by densitometry analysis using ImageJ software. The fold increase
values of MMP-2 in culture supernatant (b) and cellular fraction (d) as compared with the control are shown. *Significant difference (p < 0.05) as
compared with the data at 24 h.
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HGFs. Notably, the MAPK pathway but not NF-κB was
significantly involved in the regulation of MMP-3 expres-
sion in HGFs in both mRNA and protein levels. Previous
studies have also proven that the expression of MMP-3 is
mainly mediated through P38 MAPK, ERK and tyrosine
kinase pathways, but not through NF-κB pathway
[23,59,60]. Moreover, although a study reported that the
activation of NF-κB could be important for MMP-3 se-
cretion, no consensus NF-κB binding site was identified
in the MMP-3 gene promoter [61,62]. It suggests that
NF-κB may regulate the expression of this gene through
different binding sites or interacting with other transcrip-
tion factors [59]. Therefore, within the context and limi-
tations of the present study, it is tempting to speculate
that MAPK pathway may be crucial for MMP-3 expres-
sion in HGFs in response to P. gingivalis LPS1690. Fur-
thermore, it would be interesting to extend the study to
other cells types in human gingiva like gingival epithelial
cells to ascertain whether MAPK pathway plays apredominant role in the expression and regulation of
MMP-3 in other cells of oral tissues.
Conclusions
The present study reveals that HGFs significantly ex-
press MMP-3 in response to penta-acylated P. gingivalis
LPS1690 and hexa-acylated E. coli LPS, but not to the
tetra-acylated P. gingivalis LPS1435/1449 in HGFs. Blocking
p38 MAPK and ERK pathways significantly down-
regulates P. gingivalis LPS1690- and E. coli LPS-induced
expression of MMP-3. These findings indicate that the
heterogeneous lipid A structures of P. gingivalis LPS dif-
ferentially modulate the expression of MMP-3 in HGFs,
which may play a role in periodontal pathogenesis.
Methods
Preparation, purification and identification of P. gingivalis
LPS
P. gingivalis LPS was isolated from P. gingivalis ATCC
33277 (the American Type Culture Collection, Rockville,
Figure 6 Effects of NF-ĸB and MAPK inhibitors on P. gingivalis LPS1690-induced MMP-3 mRNA (a) and protein (b) expression in HGFs.
Cells were pretreated with IKK-2 inhibitor IV (NF-ĸB inhibitor), SB202190 (p38 MAPK inhibitor) and U1026 (ERK inhibitor) in serum free medium for
1 h, and then treated with P. gingivalis (Pg) LPS1690 (1 μg/ml) and E. coli LPS(1 μg/ml) for additional 12 h. Total RNA was harvested and MMP-3
mRNA levels were determined by real-time qPCR. Cell culture supernatants were collected and the protein expression level was measured by
ELISA. The histogram shows quantitative representations of the MMP-3 mRNA levels of three independent experiments. Each value represents the
mean ± SD. *Significant difference (p < 0.05) as compared with the controls. #Significant difference (p < 0.05) as compared with the cells treated
with P. gingivalis LPS1690 or E. coli LPS alone.
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cedure followed by lipid extraction and conversion to so-
dium salts as previously described [63,64]. Optical
densities were measured at 280 nm and 260 nm to verify
the nucleic acid and protein contamination. LPS prepa-
rations were further treated to remove the endotoxin
protein and the final protein contamination was less than
0.1% [65]. The fatty acid composition of P. gingivalis LPS
was further analysed by Gas chromatographic-mass
spectroscopy. Then two separate extractions of P.
gingivalis LPS with tetra- (LPS1435/1449) and penta-
acylated (LPS1690) lipid A structures were generated,
and their structures were verified by matrix-assisted laserdesorption ionization time-of-flight mass spectrometry.
The canonical hexa-acylated LPS of Escherichia coli JM
83-wild type strain was used as the reference [66].
Cell culture
HGFs were obtained from Sciencell research laboratories
(Carlsbad, CA, USA) and cultured according to the
manufacturer’s instructions [67,68]. Continuous subcul-
tures up to 10th passage contained homogeneous, slim
and spindle-shaped cells growing in characteristic swirls.
Third to fourth passages of HGFs without any signs of
senescence were used for all experiments as described in
our previous study [4].
Table 1 Nucleotide sequence of real-time qPCR primers
Primers Sequence (50-30)
MMP1-F ATG CTG AAA CCC TGA AGG TG
MMP1-R CTG CTT GAC CCT CAG AGA CC
MMP2-F AGG GCA CAT CCT ATG ACA GC
MMP2-R ATT TGT TGC CCA GGA AAG TG
MMP3-F GCA GTT TGC TCA GCC TAT CC
MMP3-R GAG TGT CGG AGT CCA GCT TTC
TIMP1-F CTG TTG TTG CTG TGG CTG AT
TIMP1-R TCC GTC CAC AAG CAA TGA GT
β-actin -F TTG GCA ATG AGC GGT T
β-actin -R AGTTGAAGGTAGTTTCGTGGAT
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The cells suspended at 105 cell/ml were seeded on six-
well-plates and grown until confluent at 37°C with 5%
CO2 in a culture medium for fibroblasts consisting of
basal medium with 2% fetal bovine serum, penicillin/
streptomycin (0.01% w/v) and fibroblast growth supple-
ment. Once the cells were over 90% confluent, fibroblast
medium (FM) was replaced entirely with serum free and
animal component free-medium (FM-acf) for the dose-
and time-dependent experiments. In the dose-dependent
assay, cells were stimulated with P. gingivalis LPS1435/1449,
P. gingivalis LPS1690 or E. coli LPS in the media containing
various doses of LPS (0.001 μg/ml −10 μg/ml). Subse-
quently, 1 μg of LPS was selected as the appropriate dose
for the following time-dependent experiments. Cells were
incubated with P. gingivalis LPS or E. coli LPS at 1 μg/ml
and harvested at 2, 12, 24 and 48 h. Cells without LPS
treatment were designated as the controls. Culture super-
natants were collected and centrifuged to remove the cel-
lular debris and stored at −70°C for subsequent protein
assays. Cellular fraction was then washed with PBS and
collected for mRNA and protein extraction.
RNA extraction, cDNA synthesis and real-time qPCR
Total RNA extraction, cDNA transcription and real-time
qPCR for MMPs1-3 and TIMP-1 were performed as pre-
viously described [17]. In brief, total RNA was extracted
from the homogenized HGFs using RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions [35]. cDNA was synthesized by re-
verse transcriptase-PCR at 43°C for 90 min in a 20 μl of
reaction mixture containing 1 μg of total RNA, 1 μl
(200 U) of SuperScript™ First-Strand Synthesis System
(Invitrogen Corp., Carlsbad, CA, USA), 0.5 μg of oligo
dT-primer, first-strand buffer, 10 mM DTT, and 1 mM
dNTPs. A control reaction was performed without re-
verse transcriptase for all samples to verify the absence
of genomic DNA contamination. Real-time qPCR was
then performed by using the StepOne Real-Time PCRSystem (Applied Biosystems, Foster City, CA) in at least
three separate experiments. Amplification reactions were
undertaken in 20 μl of reaction mixture containing 10 μl
of Power SYBRW Green PCR Master Mix, 1 μl of cDNA
template and 1 μl of each pair of primers for the
targeting cytokine genes (Sigma, St. Louis, MO, USA).
Real-time primer pairs were designed using ABI software
to amplify a sequence that contains two or more exons
whenever possible. The amplification efficiencies of the
primers used were above 90%. The specific sequences
for each pair of primers are listed in Table 1. β-actin was
amplified as an internal control. The real-time qPCR re-
action conditions were set at 95°C for 10 min followed
by 40 cycles at 95°C for 15 s and 60°C for 60 s. The
results were analyzed using the comparative cycle
threshold (Ct) method as previously described [35].
The expression level of each gene was normalized to a
β-actin (ΔCt) and the fold changes for each gene were
calculated by comparing the test and control samples
from the ΔΔCt values.
Total protein extraction and detection of MMP-3 by ELISA
Total proteins were extracted from homogenized HGFs
using CellLyticTM MT-mammalian cell lysis extraction
reagent (Sigma, USA). Protein concentrations in both of
the cell-bound fraction and culture supernatant were
measured respectively by BCA protein assay kit (Pierce,
Thermo Scientific, USA) according to the manufacturer’s
instructions. Enzyme-linked immunosorbent assay (ELISA)
was performed to confirm the expression of MMP-3 pro-
teins (BioRad Laboratories, Hercules, CA, USA). The pro-
tein expression in both cell lysate and culture supernatants
were measured following manufacturer’s instruction with
the minimal detectable concentration of 0.009 ng/ml. No
cross reactivity or no interference was observed with re-
combinant MMP-3. The absorbance values were deter-
mined by a micro-plate reader (Victor, Vienna, VA, USA)
at optical absorbance of 450 nm and the final concentra-
tion was determined with reference to a standard curve.
Experiments were repeated two times with three biological
replicates.
Western blot analysis for MMP-2, -3 and TIMP-1 proteins
Total cell lysates were prepared and 40 μg of cellular ex-
tracts were separated by 10% SDS-PAGE gel and subse-
quently transferred onto a polyvinylidene difluoride
membrane (PVDF). The proteins were then blocked
against the protein-free blocking buffer (Pierce, Thermo
Scientific) for 1 h. Afterwards, membranes were incu-
bated overnight at 4°C with primary antibodies against
polyclonal rabbit anti-human IgG; MMP-2 (1:1000; Cell
signaling), MMP-3 (1:1000; BioVendor) and TIMP-1
(1:1000; Cell signaling), and incubated with horseradish
peroxidase (HRP) conjugated anti-rabbit secondary antibodies
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accomplished by the use of SuperSignal West Pico Chemilu-
minescent Substrate (Thermo Scientific, Rockford, IL, USA)
and exposed to X-ray films. α-Tubulin was used as the in-
ternal loading control (1:1000; Cell signaling). The
detected bands were scanned on a calibrated densitometer,
GS-800 and assessed by the imageJ software-based ana-
lysis (http://rsb.info.nih.gov/ij/) to quantify the integrated
density.
Gelatin zymography for enzymatic activity of MMP-2
SDS-PAGE gelatin zymography was performed to ob-
serve the enzymatic activity of MMP-2. Supernatants
and cellular proteins were collected from cells grown in
serum-free medium at 24 h and 48 h as described above.
Centrifugal filter devices (Amicon Ultra-0.5-Millipore
USA) with a cut off value of 30000 NMWL (Nominal
Molecular Weight Limit) were used to concentrate the
supernatants. Culture supernatants or cellular extracts
(40 μg) were mixed with 2 × non-reducing sample buffer
without β-mercaptoethanol (0.125 M Tris–HCl at pH 6.8,
4% SDS, 20% glycerol and 0.05% bromophenol blue). Pro-
teins were separated by 10% Tris-glycine polyacrylamide
gel copolymerized with 0.1% gelatin as a substrate. After
electrophoresis, gels were washed in renaturation buffer
(2.5% Triton X-100 in 50 mM Tris–HCl at pH 7.5) for 1 h
and incubated for 20 h at 37°C in incubation buffer
(0.15 M NaCl, 10 mM CaCl2 and 0.02% NaN3 in 50 mM
Tris–HCl at pH 7.5). Gels were stained with 5%
Coomassie blue and destained with 7% methanol and 5%
acetic acid to reveal zones of lysis within the gelatin
matrix. Areas of enzymatic activity appeared as clear
bands over the dark background.
Signal transduction pathways involved in LPS-induced
MMP-3 expression in HGFs
Specific pharmacological inhibitors for NF-κB activity,
IKK-β inhibitor (IKK-2 inhibitor IV), p38 MAPK activity
(SB202190) and ERK activity (U1026) were used to in-
vestigate two major signaling pathways potentially in-
volved in the expression and regulation of MMP-3 in
HGFs in response to heterogeneous P. gingivalis LPS.
Each inhibitor was first dissolved in dimethyl sulfoxide
(DMSO) and diluted in DPBS. Cells were pretreated
with kinase inhibitors, including 10 μmol/L of IKK-2
inhibitor IV (Merck, USA), 10 μmol/L of SB202190
(Calbiochem Biosciences Inc, La Jolla, CA, USA) and
15 μmol/L of U1026 (Cell Signaling, USA) respectively
for one hour, prior to stimulation with LPS. After-
wards, 1 μg/ml of LPS was added to the medium and
cells were incubated for another 12 h. Culture super-
natants were collected for analyzing the MMP-3 ex-
pression by ELISA. Extracted RNA was subjected to
real-time qPCR to detect the MMP-3 transcriptexpression. Positive controls were the supernatants
from the cells treated with LPS alone, whereas the
negative controls were incubated with the culture
medium alone. In addition, the cells treated with DMSO
alone were considered as the vehicle control (data not
shown).
Statistical analysis
All experiments were repeated in three assays for real-
time qPCR and two assays for ELISA. Results of the ex-
periments were presented as the mean ± SD. The statis-
tical significance of difference between the data sets
from the dose-dependent assay was evaluated by student
t-test, one-way analysis of variance (ANOVA) and post
hoc testing with Bonferroni and LSD methods. Additionally,
the repeated-measures of ANOVA were used to determine
the differences between data sets from the time-dependent
assay. A p-value < 0.05 was considered statistically signifi-
cant. All statistical analysis was performed using a software
program (SPSS 19.0, SPSS Inc, Chicago, IL, USA).
Abbreviations
Pg: P. gingivalis; LPS: Lipopolysaccharides; HGFs: Human gingival fibroblasts;
MMPs: Matrix metalloproteinases; TIMP: Tissue inhibitors of
metalloproteinases; qPCR: Quantitative PCR; ELISA: Enzyme linked
immunosorbent assay; NF-κB: Nuclear factor-kappaB; MAPK: Mitogen-
activated protein kinase.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TDKH, CJS and LJJ conceived the study. RPD carried out the preparation,
purification and identification of P. gingivalis LPS. TDKH and CJS performed
the cell culture of HGFs, RNA extraction, cDNA synthesis and real-time qPCR,
ELISA, Western blot, gelatin zymography, and detection of signal
transduction pathways. RPD, CYW, YW and LJJ were involved in supervision
of the experiments and provided reagents and materials. TDKH, CJS and LJJ
analyzed the data, and wrote the manuscript. All authors read and approved
the final manuscript.
Acknowledgements
The authors are grateful to Mr. Alan Wong and Ms. Becky Cheung from the
Centralized Research Laboratory at the Faculty of Dentistry, The University of
Hong Kong, for their technical assistance. This study was financially
supported by the Hong Kong Research Grants Council (HKU766909 M,
HKU768411 M and HKU767512 M to LJJ) and the Modern Dental Laboratory/
HKU Endowment Fund to LJJ.
Author details
1Faculty of Dentistry, Periodontology, The University of Hong Kong 34
Hospital Road, Hong Kong SAR, China. 2Department of Pharmacology and
Pharmacy, Faculty of Medicine, The University of Hong Kong Hong Kong
SAR, China. 3School of Dentistry, University of Washington Seattle, WA, USA.
4School of Dentistry, University of California Los Angeles, CA, USA.
Received: 13 November 2012 Accepted: 15 March 2013
Published: 30 March 2013
References
1. Jin LJ, Armitage GC, Klinge B, Lang NP, Tonetti M, Williams RC: Global oral
health inequalities: task group–periodontal disease. Adv Dent Res 2011,
23:221–226.
2. Darveau RP: Periodontitis: a polymicrobial disruption of host
homeostasis. Nat Rev Microbiol 2010, 8:481–490.
Herath et al. BMC Microbiology 2013, 13:73 Page 11 of 12
http://www.biomedcentral.com/1471-2180/13/733. Dixon DR, Darveau RP: Lipopolysaccharide heterogeneity: innate host
responses to bacterial modification of lipid a structure. J Dent Res 2005,
84:584–595.
4. Herath TD, Wang Y, Seneviratne CJ, Lu Q, Darveau RP, Wang CY, Jin L:
Porphyromonas gingivalis lipopolysaccharide lipid a heterogeneity
differentially modulates the expression of IL-6 and IL-8 in human
gingival fibroblasts. J Clin Periodontol 2011, 38:694–701.
5. Hosokawa I, Hosokawa Y, Ozaki K, Yumoto H, Nakae H, Matsuo T:
Proinflammatory effects of muramyldipeptide on human gingival
fibroblasts. J Periodontal Res 2010, 45:193–199.
6. Mahanonda R, Sa-Ard-Iam N, Montreekachon P, Pimkhaokham A,
Yongvanichit K, Fukuda MM, Pichyangkul S: IL-8 and IDO expression by
human gingival fibroblasts via TLRs. J Immunol 2007, 178:1151–1157.
7. Phipps RP, Borrello MA, Blieden TM: Fibroblast heterogeneity in the
periodontium and other tissues. J Periodontal Res 1997, 32:159–165.
8. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B,
DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol
Med 1993, 4:197–250.
9. Hannas AR, Pereira JC, Granjeiro JM, Tjaderhane L: The role of matrix
metalloproteinases in the oral environment. Acta Odontol Scand 2007,
65:1–13.
10. Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, Golub LM,
Brown DL, Mantyla P: Matrix metalloproteinases: contribution to
pathogenesis, diagnosis and treatment of periodontal inflammation. Ann
Med 2006, 38:306–321.
11. Brew K, Dinakarpandian D, Nagase H: Tissue inhibitors of
metalloproteinases: evolution, structure and function. Biochim Biophys
Acta 2000, 1477:267–283.
12. Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, Takagi
R, Yoshie H: Altered gene expression levels of matrix metalloproteinases
and their inhibitors in periodontitis-affected gingival tissue. J Periodontol
2008, 79:166–173.
13. Seguier S, Gogly B, Bodineau A, Godeau G, Brousse N: Is collagen breakdown
during periodontitis linked to inflammatory cells and expression of matrix
metalloproteinases and tissue inhibitors of metalloproteinases in human
gingival tissue? J Periodontol 2001, 72:1398–1406.
14. Sorsa T, Tjaderhane L, Salo T: Matrix metalloproteinases (MMPs) in oral
diseases. Oral Dis 2004, 10:311–318.
15. Lagente V, Boichot E: Role of matrix metalloproteinases in the inflammatory
process of respiratory diseases. J Mol Cell Cardiol 2010, 48:440–444.
16. Agarwal S, Misra R, Aggarwal A: Induction of metalloproteinases
expression by TLR ligands in human fibroblast like synoviocytes from
juvenile idiopathic arthritis patients. Indian J Med Res 2010, 131:771–779.
17. Marsh PD: Dental plaque as a biofilm and a microbial community -
implications for health and disease. BMC Oral Health 2006, 6(Suppl 1):S14.
18. Moore WE, Moore LV: The bacteria of periodontal diseases. Periodontol
1994, 5:66–77.
19. Kerrigan JJ, Mansell JP, Sandy JR: Matrix turnover. J Orthod 2000, 27:227–233.
20. Pattamapun K, Tiranathanagul S, Yongchaitrakul T, Kuwatanasuchat J,
Pavasant P: Activation of MMP-2 by Porphyromonas gingivalis in human
periodontal ligament cells. J Periodont Res 2003, 38:115–121.
21. Sakaki H, Matsumiya T, Kusumi A, Imaizumi T, Satoh H, Yoshida H, Satoh K,
Kimura H: Interleukin-1beta induces matrix metalloproteinase-1
expression in cultured human gingival fibroblasts: role of
cyclooxygenase-2 and prostaglandin E2. Oral Dis 2004, 10:87–93.
22. Wang L, Zhang ZG, Zhang RL, Gregg SR, Hozeska-Solgot A, LeTourneau Y,
Wang Y, Chopp M: Matrix metalloproteinase 2 (MMP2) and MMP9
secreted by erythropoietin-activated endothelial cells promote neural
progenitor cell migration. J Neurosci 2006, 26:5996–6003.
23. Domeij H, Yucel-Lindberg T, Modeer T: Signal pathways involved in the
production of MMP-1 and MMP-3 in human gingival fibroblasts. Eur J
Oral Sci 2002, 110:302–306.
24. Ruwanpura SM, Noguchi K, Ishikawa I: Prostaglandin E2 regulates
interleukin-1beta-induced matrix metalloproteinase-3 production in
human gingival fibroblasts. J Dent Res 2004, 83:260–265.
25. Tewari DS, Qian Y, Tewari M, Pieringer J, Thornton RD, Taub R, Mochan EO:
Mechanistic features associated with induction of metalloproteinases in
human gingival fibroblasts by interleukin-1. Arch Oral Biol 1994,
39:657–664.
26. Letra A, Silva RM, Rylands RJ, Silveira EM, de Souza AP, Wendell SK, Garlet
GP, Vieira AR: MMP3 and TIMP1 variants contribute to chronicperiodontitis and may be implicated in disease progression. J Clin
Periodontol 2012, 39:707–716.
27. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS: Matrix
metalloproteinases, their physiological inhibitors and osteoclast factors
are differentially regulated by the cytokine profile in human periodontal
disease. J Clin Periodontol 2004, 31:671–679.
28. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr: Microbial
complexes in subgingival plaque. J Clin Periodontol 1998, 25:134–144.
29. Hajishengallis G, Darveau RP, Curtis MA: The keystone-pathogen
hypothesis. Nat Rev Microbiol 2012, 10:717–725.
30. Hajishengallis G, Liang S, Payne MA, Hashim A, Jotwani R, Eskan MA,
McIntosh ML, Alsam A, Kirkwood KL, Lambris JD, Darveau RP, Curtis MA:
Low-abundance biofilm species orchestrates inflammatory periodontal
disease through the commensal microbiota and complement. Cell Host
Microbe 2011, 10:497–506.
31. Darveau RP, Hajishengallis G, Curtis MA: Porphyromonas gingivalis as a
potential community activist for disease. J Dent Res 2012, 91:816–820.
32. Hajishengallis G: Porphyromonas gingivalis-host interactions: open war or
intelligent guerilla tactics? Microbes Infect 2009, 11:637–645.
33. Lamont RJ, Jenkinson HF: Life below the gum line: pathogenic
mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev 1998,
62:1244–1263.
34. Ding PH, Wang CY, Darveau RP, Jin LJ: Porphyromonas gingivalis LPS
stimulates the expression of LPS-binding protein in human oral
keratinocytes in vitro. Innate Immun 2013, 19:66–75.
35. Lu Q, Darveau RP, Samaranayake LP, Wang CY, Jin LJ: Differential
modulation of human β-defensins expression in human gingival
epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra-
and penta-acylated lipid a structures. Innate Immun 2009, 15:325–335.
36. Andrian E, Grenier D, Rouabhia M: Porphyromonas gingivalis-epithelial cell
interactions in periodontitis. J Dent Res 2006, 85:392–403.
37. Kou Y, Inaba H, Kato T, Tagashira M, Honma D, Kanda T, Ohtake Y, Amano
A: Inflammatory responses of gingival epithelial cells stimulated with
Porphyromonas gingivalis vesicles are inhibited by hop-associated
polyphenols. J Periodontol 2008, 79:174–180.
38. Kraus D, Winter J, Jepsen S, Jager A, Meyer R, Deschner J: Interactions of
adiponectin and lipopolysaccharide from Porphyromonas gingivalis on
human oral epithelial cells. PLoS One 2012, 7:e30716.
39. Andrian E, Grenier D, Rouabhia M: Porphyromonas gingivalis
lipopolysaccharide induces shedding of syndecan-1 expressed by
gingival epithelial cells. J Cell Physiol 2005, 204:178–183.
40. Hyc A, Osiecka-Iwan A, Niderla-Bielinska J, Moskalewski S: Influence of LPS,
TNF, TGF-ss1 and IL-4 on the expression of MMPs, TIMPs and selected
cytokines in rat synovial membranes incubated in vitro. Int J Mol Med
2011, 27:127–137.
41. Haglund L, Bernier SM, Onnerfjord P, Recklies AD: Proteomic analysis of the
LPS-induced stress response in rat chondrocytes reveals induction of
innate immune response components in articular cartilage. Matrix Biol
2008, 27:107–118.
42. Santangelo KS, Johnson AL, Ruppert AS, Bertone AL: Effects of hyaluronan
treatment on lipopolysaccharide-challenged fibroblast-like synovial cells.
Arthritis Res Ther 2007, 9:R1.
43. Castaño JP, Faught WJ, Glavé EE, Russell BS, Frawley LS: Discordance of
prolactin gene transcription, mRNA storage, and hormone release in
individual mammotropes. Am J Physiol 1997, 272:390–396.
44. Vogel C, Marcotte EM: Insights into the regulation of protein abundance from
proteomic and transcriptomic analyses. Nat Rev Genet 2012, 13:227–232.
45. Alpagot T, Bell C, Lundergan W, Chambers DW, Rudin R: Longitudinal
evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for
progression of periodontitis. J Clin Periodontol 2001, 28:353–359.
46. Haerian A, Adonogianaki E, Mooney J, Manos A, Kinane DF: Effects of
treatment on gingival crevicular collagenase, stromelysin and tissue
inhibitor of metalloproteinases and their ability to predict response to
treatment. J Clin Periodontol 1996, 23:83–91.
47. Nomura T, Ishii A, Oishi Y, Kohma H, Hara K: Tissue inhibitors of
metalloproteinases level and collagenase activity in gingival crevicular
fluid: the relevance to periodontal diseases. Oral Dis 1998, 4:231–240.
48. Tuter G, Kurtis B, Serdar M, Yucel A, Ayhan E, Karaduman B, Ozcan G: Effects
of phase I periodontal treatment on gingival crevicular fluid levels of
matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1.
J Clin Periodontol 2005, 32:1011–1015.
Herath et al. BMC Microbiology 2013, 13:73 Page 12 of 12
http://www.biomedcentral.com/1471-2180/13/7349. Zhou J, Windsor LJ: Porphyromonas gingivalis affects host collagen
degradation by affecting expression, activation, and inhibition of matrix
metalloproteinases. J Periodont Res 2006, 41:47–54.
50. Kawai T, Akira S: TLR signaling. Semin Immunol 2007, 19:24–32.
51. Takeda K, Akira S: TLR signaling pathways. Semin Immunol 2004, 16:3–9.
52. Cortez DM, Feldman MD, Mummidi S, Valente AJ, Steffensen B, Vincenti M,
Barnes JL, Chandrasekar B: IL-17 stimulates MMP-1 expression in primary
human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-
beta, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 2007,
293:H3356–H3365.
53. Gao D, Bing C: Macrophage-induced expression and release of matrix
metalloproteinase 1 and 3 by human preadipocytes is mediated by IL-
1beta via activation of MAPK signaling. J Cell Physiol 2011, 226:2869–2880.
54. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM: Differential regulation
of lipopolysaccharide-induced monocyte matrix metalloproteinase
(MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase
1/2 mitogen-activated protein kinases. J Immunol 2003, 170:6244–6249.
55. McCawley LJ, Li S, Wattenberg EV, Hudson LG: Sustained activation of the
mitogen-activated protein kinase pathway. A mechanism underlying
receptor tyrosine kinase specificity for matrix metalloproteinase-9
induction and cell migration. J Biol Chem 1999, 274:4347–4353.
56. Reunanen N, Westermarck J, Hakkinen L, Holmstrom TH, Elo I, Eriksson JE, Kahari
VM: Enhancement of fibroblast collagenase (matrix metalloproteinase-1) gene
expression by ceramide is mediated by extracellular signal-regulated and
stress-activated protein kinase pathways. J Biol Chem 1998, 273:5137–5145.
57. Bond M, Baker AH, Newby AC: Nuclear factor kappaB activity is essential
for matrix metalloproteinase-1 and −3 upregulation in rabbit dermal
fibroblasts. Biochem Biophys Res Commun 1999, 264:561–567.
58. Bond M, Chase AJ, Baker AH, Newby AC: Inhibition of transcription factor
NF-kappaB reduces matrix metalloproteinase-1, -3 and −9 production by
vascular smooth muscle cells. Cardiovasc Res 2001, 50:556–565.
59. Fukuda K, Fujitsu Y, Kumagai N, Nishida T: Inhibition of matrix
metalloproteinase-3 synthesis in human conjunctival fibroblasts by
interleukin-4 or interleukin-13. Invest Ophthalmol Vis Sci 2006, 47:2857–2864.
60. Kajanne R, Miettinen P, Mehlem A, Leivonen SK, Birrer M, Foschi M, Kähäri
VM, Leppä S: EGF-R regulates MMP function in fibroblasts through MAPK
and AP-1 pathways. J Cell Physiol 2007, 212:489–497.
61. Chase AJ, Bond M, Crook MF, Newby AC: Role of nuclear factor-kappa B
activation in metalloproteinase-1, -3, and −9 secretion by human
macrophages in vitro and rabbit foam cells produced in vivo. Arterioscler
Thromb Vasc Biol 2002, 22:765–771.
62. Frisch SM, Ruley HE: Transcription from the stromelysin promoter is
induced by interleukin-1 and repressed by dexamethasone. J Biol Chem
1987, 262:16300–16304.
63. Al-Qutub MN, Braham PH, Karimi-Naser LM, Liu X, Genco CA, Darveau RP:
Hemin-dependent modulation of the lipid A structure of Porphyromonas
gingivalis lipopolysaccharide. Infect Immun 2006, 74:4474–4485.
64. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald
WN, Way SS, Hajjar AM: Porphyromonas gingivalis lipopolysaccharide
contains multiple lipid a species that functionally interact with both toll-
like receptors 2 and 4. Infect Immun 2004, 72:5041–5051.
65. Manthey CL, Perera PY, Henricson BE, Hamilton TA, Qureshi N, Vogel SN:
Endotoxin-induced early gene expression in C3H/HeJ (Lpsd)
macrophages. J Immunol 1994, 153:2653–2663.
66. Bainbridge BW, Coats SR, Pham TT, Reife RA, Darveau RP: Expression of a
Porphyromonas gingivalis lipid a palmitylacyltransferase in Escherichia
coli yields a Chimeric lipid a with altered ability to stimulate interleukin-
8 secretion. Cell Microbiol 2006, 8:120–129.
67. Di Domenico G, Del Vecchio L, Postiglione L, Ramaglia L:
Immunophenotypic analysis of human gingival fibroblasts and its
regulation by granulocyte-macrophage colony-stimulating factor
(GM-CSF). Minerva Stomatol 2003, 52:87–91.
68. Poggi P, Rodriguez Y, Baena R, Rizzo S, Rota MT: Mouthrinses with alcohol:
cytotoxic effects on human gingival fibroblasts in vitro. J Periodontol
2003, 74:623–629.
doi:10.1186/1471-2180-13-73
Cite this article as: Herath et al.: The expression and regulation of matrix
metalloproteinase-3 is critically modulated by Porphyromonas gingivalis
lipopolysaccharide with heterogeneous lipid A structures in human
gingival fibroblasts. BMC Microbiology 2013 13:73.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
